News Center_News Center

The birth of Likang V-01 indicates a new leap in R&D and innovation

The birth of Likang V-01 indicates a new leap in R&D and innovation

2022-11-29

View details

Expert consensus: Livzon Antiviral Granules are recommended for mild and common infections of COVID-19

2022-04-20

View details

Livzon Rapid Test for 2019-nCoV-2 Antigen (Lateral Flow) approved by China NMPA.

2022-04-20

View details

A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed and manufactured by Livzon has shown good protective effects against the Omicron variant in a phase III clinical booster trial

2022-04-20

View details

Livzon Pharmaceutical Group was recognized as the National Enterprise Technology Center with High Scores

2022-04-20

View details

Livzon participated in the 39th Annual JP Morgan Medical Health Conference

2021-01-15

View details

Environmental，Social and Governance Report 2019

2020-04-15

Since the new round of medical and health system reforms launched in China in 2009, a complete basic
medical insurance system has been gradually established and major health indicators of the residen

View details

Since the new round of medical and health system reforms launched in China in 2009, a complete basic
medical insurance system has been gradually established and major health indicators of the residen

Zhu Baoguo Won the TNC Oak Leaf Award

Zhu Baoguo Won the TNC Oak Leaf Award

2018-12-26

OnthenightofJune21,2017,Mr.ZhuBaoguo,theChairmanofLivzonPharmaceuticalGroupInc.andamemberoftheTheNatureConservancy(TNC)GreatChinaCouncil,receivedtheTNC-OakLeafAwardinrecognitionofhisremarkablecontribu

View details

OnthenightofJune21,2017,Mr.ZhuBaoguo,theChairmanofLivzonPharmaceuticalGroupInc.andamemberoftheTheNatureConservancy(TNC)GreatChinaCouncil,receivedtheTNC-OakLeafAwardinrecognitionofhisremarkablecontribu